Sponsor:
UCLA
Code:
NCT05304065
Conditions
Suicide
Suicidal
Self-Harm
Eligibility Criteria
Sex: All
Age: 13 - 24
Healthy Volunteers: Not accepted
Interventions
SAFETY-A within usual ED Care
Combined SAFETY-A within usual ED Care + CLASP Therapeutic Follow-Up Contacts
Brief summary:
Conditions
Suicide
Suicidal
Self-Harm
Study ID
NCT05304065
Start date
Oct 17, 2022
Status verified date
Dec, 2025
Completion date
Dec 31, 2026
Anticipated
Primary completion date
Dec 31, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 13 - 24
Healthy Volunteers: Not accepted
Enrollment
1600 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
active comparator: SAFETY-Acute within Usual ED Care
active comparator: Combined
Interventions
SAFETY-A within usual ED Care
Combined SAFETY-A within usual ED Care + CLASP Therapeutic Follow-Up Contacts
Primary outcome measure
Central contacts
Locations
Ronald Reagan Medical Center
Recruiting
Los Angeles, California, United States, 90095-6968
Contacts
Olive View UCLA Education and Research Center
Recruiting
Sylmar, California, United States, 91342
Contacts
Duke University
Recruiting
Durham, North Carolina, United States, 27708
Contacts
David Goldston, Ph.D.
david.goldston@duke.eduBrown University
Recruiting
Providence, Rhode Island, United States, 02912
Contacts
Anthony Spirito, Ph.D.
anthony_spirito@brown.eduUniversity of Utah
Recruiting
Salt Lake City, Utah, United States, 84112
Contacts
Brooks Keeshin, MD
brooks.keeshin@hsc.utah.eduSponsor
University of California, Los Angeles
Last update posted
Dec 31, 2025
Last verified
Dec, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of California, Los Angeles on 2025-12-31.